BioRegenx, a healthcare company that sells and markets patented nutraceuticals, dietary supplements, and medical imaging devices, completed the acquisition of DocSun Biomedical, a social project that is developing AI-powered health monitor technology. Financial terms were not disclosed. "I'm excited about the addition of DocSun to our family. Their accomplished management team and leading-edge technology now form an integral part of BioRegenx's product line, positioning DocSun as our third revenue-producing subsidiary," William Resides, BioRegenx CEO.